CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts. [electronic resource]

By:

Laurent, Lucie

Contributor(s):

Sefrioui, David
Bignon, Anne-Laure
Parzy, Aurélie
Sidali, Sabrina
Hassine, Mélanie
Gangloff, Alice
Galais, Marie-Pierre
Bouhier-Leporrier, Karine
Michel, Pierre
Di Fiore, Frédéric

Producer: 20200408Description: 582-588 p. digitalISSN:

1477-2574

Subject(s):

Adenocarcinoma -- metabolism
Adult
Aged
Aged, 80 and over
Bilirubin -- metabolism
Biomarkers, Tumor -- metabolism
CA-19-9 Antigen -- metabolism
Disease Progression
Female
France
Humans
Male
Middle Aged
Pancreatic Neoplasms -- metabolism
Retrospective Studies
Sensitivity and Specificity

Online resources:

Available from publisher's website

In: HPB : the official journal of the International Hepato Pancreato Biliary Association vol. 21

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Multicenter Study

There are no comments on this title.

CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts.

APA

Laurent L., Sefrioui D., Bignon A., Parzy A., Sidali S., Hassine M., Gangloff A., Galais M., Bouhier-Leporrier K., Michel P. & Di Fiore F. (20200408). CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts. : HPB : the official journal of the International Hepato Pancreato Biliary Association.

Chicago

Laurent Lucie, Sefrioui David, Bignon Anne-Laure, Parzy Aurélie, Sidali Sabrina, Hassine Mélanie, Gangloff Alice, Galais Marie-Pierre, Bouhier-Leporrier Karine, Michel Pierre and Di Fiore Frédéric. 20200408. CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts. : HPB : the official journal of the International Hepato Pancreato Biliary Association.

Harvard

Laurent L., Sefrioui D., Bignon A., Parzy A., Sidali S., Hassine M., Gangloff A., Galais M., Bouhier-Leporrier K., Michel P. and Di Fiore F. (20200408). CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts. : HPB : the official journal of the International Hepato Pancreato Biliary Association.

MLA

Laurent Lucie, Sefrioui David, Bignon Anne-Laure, Parzy Aurélie, Sidali Sabrina, Hassine Mélanie, Gangloff Alice, Galais Marie-Pierre, Bouhier-Leporrier Karine, Michel Pierre and Di Fiore Frédéric. CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts. : HPB : the official journal of the International Hepato Pancreato Biliary Association. 20200408.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC